906 followers
New article: Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2- Advanced Breast Cancer https://t.co/jXQhBZEnD1 #breastcancer #oncology https://t.co/ZXSl52KwCY